Menu

Clarification of the ELM score performance tables.

Journal of hepatology · 17 Oct 2026 · Letter

Giuffrè, Colecchia + 1 more

Abstract ↗AI summary

The abstract is read at the publisher; the summary is JClub's.

The AI summary for this paper is being written. Open it in JClub to read the paper with the summary as soon as it lands.

Read the AI summary in JClub →

The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.
Cell Metabolism · 7 July 2026 · Journal Article
Semaglutide improves liver health in mice with MASH through intrahepatic sinusoidal endothelial GLP-1 receptors, independent of weight loss, with a substantial effect on fibrosis and immune remodeling.
- 3 cited this week
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41985454
Open in JClub
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.
Nature Medicine · 1 Aug 2026 · Multicenter Study
Imaging and serum biomarkers, including MRE and Agile scores, accurately diagnose cirrhosis with AUCs exceeding 0.87 in MASLD patients.
- 1 cited this week
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42498741
Open in JClub
Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Gastroenterology · 1 July 2026 · Journal Article
An updated clinical care pathway improves screening, diagnosis, and management of MASLD/MASH, guiding clinicians through a standardized approach for metabolic liver disease.
- 24 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41812830
Open in JClub

Journals this month

All journals →

Topics moving, week to 18 Oct 2026

By field

All journals by field →